We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$112B
AUM Growth
+$9.17B
Cap. Flow
+$3.28B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.06%
Holding
4,415
New
305
Increased
1,505
Reduced
1,905
Closed
456

Sector Composition

Rank Sector Weight
1 Technology 11.36%
2 Financials 11.09%
3 Healthcare 9.9%
4 Consumer Discretionary 6.79%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDEN
3326
DELISTED
Golden Entertainment
GDEN
$499K ﹤0.01%
+15,329
New +$454K
LORL
3327
DELISTED
Loral Space and Communications, Inc.
LORL
$499K ﹤0.01%
11,312
-2,971
-21% -$139K
LXRX icon
3328
Lexicon Pharmaceuticals
LXRX
$1.03B
$498K ﹤0.01%
50,474
-14,486
-22% -$151K
NTLA icon
3329
Intellia Therapeutics
NTLA
$1.51B
$498K ﹤0.01%
25,876
+2,338
+10% +$54K
OIBR.C
3330
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$498K ﹤0.01%
88,398
+7,663
+9% +$54.5K
BNED icon
3331
Barnes & Noble Education
BNED
$435M
$497K ﹤0.01%
603
-268
-31% -$177K
AAIC
3332
DELISTED
Arlington Asset Investment Corp.
AAIC
$497K ﹤0.01%
42,103
-13,580
-24% -$163K
AGRO icon
3333
Adecoagro
AGRO
$1.4B
$495K ﹤0.01%
47,925
-171,046
-78% -$1.72M
SLCA
3334
PUT
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$495K ﹤0.01%
15,200
-74,800
-83% -$2.38M
ACHN
3335
DELISTED
Achillion Pharmaceuticals
ACHN
$491K ﹤0.01%
170,897
+20,214
+13% +$73.4K
NXE icon
3336
NexGen Energy
NXE
$5.91B
$489K ﹤0.01%
191,088
-12,187
-6% -$28.3K
GNC
3337
DELISTED
GNC Holdings, Inc.
GNC
$488K ﹤0.01%
132,087
+69,883
+112% +$439K
ACET
3338
DELISTED
Aceto Corp
ACET
$487K ﹤0.01%
47,139
+5,325
+13% +$56K
ANIP icon
3339
ANI Pharmaceuticals
ANIP
$1.86B
$485K ﹤0.01%
7,519
-4,136
-35% -$257K
ITRN icon
3340
Ituran Location and Control
ITRN
$1.08B
$485K ﹤0.01%
14,173
+1,283
+10% +$45.9K
RDNT icon
3341
RadNet
RDNT
$4.98B
$485K ﹤0.01%
47,963
+20,068
+72% +$209K
RESI
3342
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$485K ﹤0.01%
40,845
-18,038
-31% -$200K
NYRT
3343
DELISTED
New York REIT, Inc.
NYRT
$484K ﹤0.01%
12,325
+3,088
+33% +$198K
AKCA
3344
DELISTED
Akcea Therapeutics Inc
AKCA
$482K ﹤0.01%
27,734
+17,701
+176% +$347K
IIIN icon
3345
Insteel Industries
IIIN
$592M
$479K ﹤0.01%
16,892
-8,917
-35% -$239K
WELL.PRI
3346
DELISTED
Welltower Inc.
WELL.PRI
$479K ﹤0.01%
8,000
LFCR icon
3347
Lifecore Biomedical
LFCR
$162M
$478K ﹤0.01%
37,930
-12,757
-25% -$161K
SFL icon
3348
SFL Corp
SFL
$1.61B
$476K ﹤0.01%
30,686
-36,805
-55% -$552K
SSYS icon
3349
Stratasys
SSYS
$666M
$476K ﹤0.01%
23,852
-17,879
-43% -$390K
SUP
3350
DELISTED
Superior Industries International
SUP
$475K ﹤0.01%
31,974
-10,150
-24% -$162K

Similar funds

Credit Suisse's Q4 2017 Portfolio in Review

As of Q4 2017, Credit Suisse held 4,415 positions worth $112B, up 8.9% from $103B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse's Q4 2017 filing shows 305 new, 1,505 increased, 1,905 reduced and 456 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 1,427,144 shares worth $104M. The largest sale was iShares MSCI South Korea ETF, an estimated $280M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Credit Suisse's largest Q4 2017 buy was Vanguard FTSE Pacific ETF: 1,427,144 shares worth $104M.
  • Credit Suisse added most to Citigroup in Q4 2017, an estimated $424M increase.
  • Credit Suisse's biggest Q4 2017 reduction was iShares MSCI South Korea ETF, cutting an estimated $280M.
  • Credit Suisse fully exited Fortress Investment Group Llc in Q4 2017, selling an estimated $86.9M.
  • Credit Suisse's ten largest holdings make up 16% of its $112B portfolio in Q4 2017.
  • Credit Suisse opened 305 new positions and closed 456 in Q4 2017.
  • Credit Suisse's portfolio value rose 8.9% quarter-over-quarter to $112B.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.